-
HIV research increasingly points to a connection between CD8 T cells and suppressed virus, but precisely how this works remains a mystery.
-
Elite suppressors are that 1% or fewer of HIV patients who do not develop signs of disease progression despite living for years without treatment.
-
Men and women infected with HIV dramtically reduced the risk of transmitting the virus to their sexual partners through initiation of oral antiretroviral therapy (ART), according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network (HPTN).
-
Can the informed consent process actually provide too much information? That's the contention of HIV researcher Susan Allen, MD, MPH, who points to a recent study she tried to conduct in Zambia of participants' knowledge about contraceptive options.
-
The Food and Drug Administration is proposing to amend its regulations to expand the scope of clinical investigator disqualification.
-
In a large, randomized, controlled trial, screening for prostate cancer did not have a significant effect on mortality from prostate cancer after 20 years of follow-up.
-
The use of low-dose aspirin is associated with an almost two-fold increase in the risk of upper gastrointestinal bleeding compared with nonuse and this risk is further increased when low-dose aspirin is combined with clopidogrel, oral anticoagulants, nonsteroidal anti-inflammatory drugs, or high-dose oral corticosteroids.
-
A tyrosine kinase inhibitor has been approved for the treatment of medullary thyroid cancer (MTC).
-
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
